latest knowledge on plasma p-tau in alzheimer’s disease
Published 1 year ago • 272 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
1:32
investigating novel plasma-based p-tau biomarkers
-
1:24
markers of of tau pathology in alzheimer’s disease
-
1:58
the value of plasma p-tau181 as a screening and diagnostic tool for alzheimer’s disease
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
2:20
the ability of plasma p-tau231 to detect preclinical alzheimer’s disease
-
5:19
examining plasma vs. csf p-tau217 in preclinical and prodromal alzheimer’s disease
-
3:13
plasma p-tau181 and p-tau231 offer complementary information in alzheimer's
-
47:25
early detection, better direction: tau biomarkers and amyloid-targeting therapies (atts) in ad
-
1:14
plasma tau levels and alzheimer’s disease: what’s the relationship?
-
2:17
potential markers for alzheimer’s disease: plasma p-tau181/aβ1-42
-
3:09
head-to-head comparison of p-tau species for alzheimer’s disease detection in a real-world cohort
-
2:33
using phosphorylated tau as a diagnostic tool for alzheimer's disease
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
1:12
beyond aβ and p-tau: novel biomarkers under investigation for alzheimer’s disease
-
0:56
blood-based biomarkers for treatment monitoring in alzheimer’s disease
-
4:33
plasma p-tau as a biomarker for cerebral amyloid angiopathy diagnosis
-
4:32
plasma tau217 occupancy as accurate as validated csf tests
-
1:45
the accuracy of plasma biomarkers for alzheimer’s disease outside of a controlled setting
-
2:07
the latest developments in alzheimer's disease